Targeting protein biotinylation enhances tuberculosis chemotherapy

Successful drug treatment for tuberculosis (TB) depends on the unique contributions of its component drugs. Drug resistance poses a threat to the efficacy of individual drugs and the regimens to which they contribute. Biologically and chemically validated targets capable of replacing individual comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiwari, Divya, Park, Sae Woong, Essawy, Maram M., Dawadi, Surendra, Mason, Alan, Nandakumar, Madhumitha, Zimmerman, Matthew, Mina, Marizel, Ho, Hsin Pin, Engelhart, Curtis A., Ioerger, Thomas, Sacchettini, James C., Rhee, Kyu, Ehrt, Sabine, Aldrich, Courtney C., Dartois, Véronique, Schnappinger, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2018
Materias:
Tuberculosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151865/
https://www.ncbi.nlm.nih.gov/pubmed/29695454
http://dx.doi.org/10.1126/scitranslmed.aal1803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151865/
https://www.ncbi.nlm.nih.gov/pubmed/29695454
http://dx.doi.org/10.1126/scitranslmed.aal1803

Ejemplares similares